Methicillin-resistant Staphylococcus aureus : impact on care in the neonatal unit
Nelson M, Bizzarro M, Gallagher P. Methicillin-resistant Staphylococcus aureus : impact on care in the neonatal unit. 2014, 41-61. DOI: 10.2217/ebo.13.571.Peer-Reviewed Original ResearchNeonatal intensive care unitMethicillin-resistant Staphylococcus aureusMRSA transmissionTreatment of MRSAIntensive care unitAppropriate treatment regimensMRSA colonizationNeonatal morbidityMRSA acquisitionCare unitIll infantsNeonatal unitSignificant morbidityTreatment regimensRisk factorsMRSA strainsPrevention strategiesNeonatesInfectionPervasive pathogenEarly detectionMorbidityStaphylococcus aureusInfantsEpidemiologyLow‐Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates
Levit OL, Calkins KL, Gibson LC, Kelley‐Quon L, Robinson DT, Elashoff DA, Grogan TR, Li N, Bizzarro MJ, Ehrenkranz RA. Low‐Dose Intravenous Soybean Oil Emulsion for Prevention of Cholestasis in Preterm Neonates. Journal Of Parenteral And Enteral Nutrition 2014, 40: 374-382. PMID: 24963025, PMCID: PMC4537394, DOI: 10.1177/0148607114540005.Peer-Reviewed Original ResearchConceptsDays of lifeIntravenous fat emulsionPreterm neonatesPrimary outcomeGestational ageControl groupControl doseFat emulsionDays of PNFull enteral feedsPrevention of cholestasisMajor neonatal morbidityHours of lifeEffective preventive strategiesLow groupHospital stayNeonatal morbidityBaseline characteristicsParenteral nutritionSecondary outcomesEnteral feedsEssential fatty acidsPremature infantsLiver diseaseTotal bilirubin